Enact Holdings, Inc. ACT
44.18 USD -0.01 (-0.02%)
Regular-session close
44.18 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
44.14 Day range 45.09
37.03 52-week range 50.56
- YTD
- +11.45%
- 1 year
- +15.81%
News
globenewswire.com Aduro Clean Technologies Advances Comparative Life Cycle Assessment of Hydrochemolytic™ Technology with Delphi LONDON, Ontario, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of…
globenewswire.com VivoSim Labs to Showcase Breakthrough Multiparametric NAMkind™ Liver and Intestine Data at the 2026 American College of Toxicology (ACT) Annual Meeting New data on 10 compounds pulled due to unforeseen liver tox highlight how VivoSim's models often easily catch clinical failure risk missed by animal models, using a complex approach that leverages…
benzinga.com Enact Holdings Q3 2026 Earnings Call Transcript Enact Holdings (NASDAQ:ACT) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…benzinga.com Enact Holdings Q3 Adj. EPS $1.19 Beats $1.18 Estimate, Sales $312.854M Miss $317.921M Estimate Enact Holdings (NASDAQ:ACT) reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $1.18 by 0.85 percent. This is a 6.25 percent increase over earnings of $1.12…
benzinga.com B of A Securities Downgrades Enact Holdings to Underperform, Lowers Price Target to $42 B of A Securities analyst Mihir Bhatia downgrades Enact Holdings (NASDAQ:ACT) from Buy to Underperform and lowers the price target from $53 to $42.
